Profile data is unavailable for this security.
About the company
Iconovo AB is a Sweden-based company, which offers inhalation solutions for pharmaceutical companies. Solutions are based on the Company’s device platforms and include formulation, analytical testing and documentation. Iconovo Ab develops products, which are a part of device family and include: ICOres, reservoir devices, ICOone, disposable unit-dose devices, ICOcap, capsule-based devices and ICOpre, pre-metered devices. Moreover, the Company offers programs, which include development of generic inhalation products, where the products are registered based on therapeutic equivalence; development of inhalation products based on a generic application programming interface (API) and new chemical entity (NCE); as well as phase I-II clinical trials using ICOone.
- Revenue in SEK (TTM)6.10m
- Net income in SEK-39.03m
- Incorporated2013
- Employees29.00
- LocationIconovo ABIdeon, Delta 6, Ideongatan 3BLUND 223 81SwedenSWE
- Phone+46 462756777
- Websitehttps://www.iconovo.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dignitana AB | 86.49m | -25.27m | 80.14m | 29.00 | -- | 8.19 | -- | 0.9265 | -0.3268 | -0.3268 | 1.13 | 0.1215 | 1.74 | 2.76 | 15.19 | 3,203,482.00 | -50.91 | -42.21 | -122.38 | -68.91 | 69.56 | 66.09 | -29.22 | -57.29 | 0.5202 | -9.97 | 0.609 | -- | 17.90 | 20.59 | 22.52 | -- | -15.31 | -- |
| Codelab Capital AS | -96.88bn | -96.88bn | 83.13m | 29.00 | -- | 0.5169 | -- | -- | -- | -- | -- | 0.4624 | -- | -- | -- | -- | -- | -6.63 | -- | -7.43 | -- | 83.80 | -- | -39.82 | -- | -- | 0.00 | -- | -69.66 | -3.83 | 119.43 | -- | -12.19 | -- |
| Kontigo Care AB | 29.65m | 1.75m | 83.32m | 10.00 | 37.47 | 1.72 | 15.71 | 2.81 | 0.0694 | 0.0694 | 1.11 | 1.51 | 0.6241 | -- | 8.03 | -- | 3.68 | -0.4214 | 5.03 | -0.6195 | 69.93 | 66.31 | 5.89 | -0.5205 | -- | 10.00 | 0.0569 | -- | 1.80 | 16.95 | -92.68 | -- | 44.94 | -- |
| SciBase Holding AB (publ) | 25.71m | -59.24m | 86.50m | 27.00 | -- | 1.64 | -- | 3.36 | -0.4495 | -0.4495 | 0.1884 | 0.2409 | 0.299 | 0.7328 | 4.04 | 952,222.30 | -68.89 | -68.63 | -89.67 | -87.77 | 70.02 | 61.28 | -230.41 | -300.20 | 3.11 | -62.08 | 0.00 | -- | 29.93 | 27.50 | -28.75 | -- | 5.15 | -- |
| Clinical Laserthermia Systems AB | 15.20m | -68.04m | 95.61m | 7.00 | -- | 1.04 | -- | 6.29 | -10.14 | -10.14 | 2.19 | 5.32 | 0.287 | 11.20 | 4.24 | -- | -130.42 | -123.49 | -460.49 | -312.95 | -249.68 | -1,084.16 | -454.45 | -1,625.03 | 0.9119 | -18.95 | 0.0116 | -- | 31.99 | 35.55 | -12.92 | -- | 18.26 | -- |
| Observe Medical ASA | -96.88bn | -96.88bn | 99.98m | 5.00 | -- | 0.6584 | -- | -- | -- | -- | -- | 0.5635 | -- | -- | -- | -- | -- | -32.60 | -- | -49.80 | -- | 32.83 | -- | -256.25 | 0.193 | -- | 0.3425 | -- | 43.14 | 204.81 | -18.82 | -- | 32.69 | -- |
| BBS-Bioactive Bone Substitutes Oyj | 0.00 | -39.51m | 102.13m | -- | -- | 1.17 | -- | -- | -0.2926 | -0.2926 | 0.00 | 0.2647 | 0.00 | -- | -- | -- | -32.71 | -25.12 | -38.23 | -28.54 | -- | -- | -- | -- | -- | -28.79 | 0.482 | -- | -- | -- | -12.64 | -- | -- | -- |
| Toleranzia AB | 0.00 | -5.41m | 102.87m | 11.00 | -- | 0.6808 | -- | -- | -0.026 | -0.026 | 0.00 | 0.7668 | 0.00 | -- | -- | 0.00 | -3.89 | -7.45 | -4.05 | -7.78 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 11.79 | -- | 63.90 | -- |
| ScandiDos AB | 61.35m | -9.67m | 103.19m | 26.00 | -- | 2.36 | -- | 1.68 | -0.2092 | -0.2092 | 1.27 | 0.766 | 0.8184 | 1.31 | 6.88 | -- | -12.90 | -12.60 | -23.54 | -21.93 | 50.39 | 51.58 | -15.76 | -15.37 | 0.9476 | -6.36 | 0.00 | -- | -1.82 | 4.36 | -60.62 | -- | -19.29 | -- |
| Redsense Medical AB (publ) | 23.77m | -3.98m | 108.54m | 5.00 | -- | 3.38 | -- | 4.57 | -0.2871 | -0.2871 | 1.65 | 1.95 | 0.7524 | 7.58 | 4.18 | 4,754,400.00 | -12.58 | -18.66 | -14.51 | -20.99 | 20.47 | -2.72 | -16.72 | -46.28 | 4.00 | -89.34 | 0.00 | -- | 74.11 | 28.94 | 48.47 | -- | -23.62 | -- |
| Luxbright AB | 4.20m | -22.23m | 112.69m | 10.00 | -- | 3.79 | -- | 26.81 | -0.24 | -0.24 | 0.0454 | 0.2641 | 0.104 | -- | 4.14 | 420,270.00 | -55.02 | -61.39 | -62.23 | -70.36 | -134.43 | -577.85 | -528.90 | -2,529.11 | 0.7743 | -4,539.47 | 0.0084 | -- | 55.58 | -- | -20.07 | -- | -- | -- |
| Episurf Medical AB | 12.10m | -84.60m | 113.80m | 26.00 | -- | 0.9675 | -- | 9.40 | -0.2429 | -0.2429 | 0.0347 | 0.1807 | 0.0839 | -- | 6.21 | 432,142.80 | -58.81 | -47.46 | -67.73 | -52.01 | -- | -- | -700.83 | -1,019.29 | 6.11 | -- | 0.0321 | -- | 53.62 | 19.78 | -22.64 | -- | -0.4158 | -- |
| Glycorex Transplantation AB (publ) | 31.03m | -27.83m | 119.29m | 15.00 | -- | 3.26 | -- | 3.84 | -0.3768 | -0.3768 | 0.4201 | 0.5186 | 0.412 | 0.8382 | 3.69 | 1,348,913.00 | -36.96 | -11.30 | -46.32 | -13.17 | 82.91 | 91.60 | -89.70 | -33.24 | 1.09 | -71.86 | 0.2084 | -- | -17.04 | -2.15 | -254.06 | -- | -0.5593 | -- |
| Iconovo AB | 6.10m | -39.03m | 119.71m | 29.00 | -- | 0.9747 | -- | 19.63 | -3.01 | -3.01 | 0.4526 | 7.71 | 0.0434 | -- | 1.04 | 210,251.40 | -27.76 | -25.43 | -31.28 | -28.24 | 323.68 | 134.57 | -640.15 | -215.16 | -- | -- | 0.0669 | -- | -58.65 | -9.88 | 4.71 | -- | 34.70 | -- |
| BibbInstruments AB | 0.00 | -11.84m | 128.49m | 4.00 | -- | 3.72 | -- | -- | -0.4417 | -0.4417 | 0.00 | 1.18 | 0.00 | -- | -- | -- | -31.46 | -39.57 | -33.52 | -42.71 | -- | 59.36 | -- | -8,032.40 | 4.34 | -- | 0.00 | -- | -- | -- | 2.72 | -- | -1.94 | -- |
| Phase Holographic Imaging PHI AB | 9.12m | -21.81m | 146.16m | 17.00 | -- | -- | -- | 16.02 | -0.8819 | -0.8819 | 0.3689 | -0.0273 | 0.2373 | 0.6598 | 1.18 | -- | -56.73 | -62.04 | -88.25 | -79.64 | 71.06 | 63.16 | -239.04 | -328.50 | 0.1916 | -5.61 | 1.04 | -- | 6.16 | 17.96 | 12.98 | -- | 21.19 | -- |
Data as of Sep 20 2024. Currency figures normalised to Iconovo AB's reporting currency: Swedish Krona SEK
7.82%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 31 Dec 2023 | 439.95k | 2.76% |
| Atle Investment Services ABas of 30 Jun 2023 | 402.00k | 2.53% |
| Cicero Fonder ABas of 31 Aug 2024 | 400.00k | 2.51% |
| FCG Fonder ABas of 30 Aug 2024 | 3.11k | 0.02% |
More ▼
Data from 30 Jun 2023 - 31 Aug 2024Source: FactSet Research Systems Inc.
